Circulatory System Respiratory Cardiology
Conditions
Interventions
treatment
no intervention
Sponsors
no sponsor
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: • age >18 years, both sexes; • written informed consent; • a recent diagnosis of COVID19 (1 - 6 months) proven by RT-PCR or viral rapid test.
Exclusion criteria
Exclusion criteria: • Age <18 years • Inability to express consent of the study • Diseases carrying out a life -expectancy <1 year according to clinical judgment • Pregnancy and breastfeeding • Foreseen inability to attend scheduled visits
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The evaluation of microvascular reactivity in post COVID-19 patients with DTM at 21-days follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| The CV events – mortality 1, 3 and 12 months after patient’s inclusion. The predefined secondary outcome was a new cardiovascular event. Patients were followed for the development of cardiovascular disease, defined as death, an acute coronary syndrome, a cerebrovascular event, pulmonary embolism or deep venous thrombosis or hospitalizations due to cardiac events. | — |
Countries
Tunisia
Contacts
Public Contactleila abid
Cardiology departement hedi chaker hospital sfax
Outcome results
None listed